SCIENCE@home

The E3 ubiquitin ligase MARCHF8 restricts HSV-1 infection by inhibiting replication of the viral genome

Yongyan Xia,L. R. Nigos,Fernando Villalón-Letelier,Melkamu B Tessema,Andrew G. Brooks,Eva Bartok,Rayk Behrendt,S. Londrigan,Patrick C. Reading,Rubaiyea Farrukee

Published 2025 in Journal of Biological Chemistry

ABSTRACT

Host cell restriction factors are intracellular proteins that target and inhibit virus replication. Membrane-associated RING-CH finger (MARCHF) proteins are a family of intracellular E3-ubiquitin ligases and some, including MARCHF8, have been implicated in restricting the replication of diverse RNA viruses. However, little is currently known as to whether MARCHF proteins mediate antiviral activity against DNA viruses. Herein, we used a doxycycline-inducible overexpression system to demonstrate that human MARCHF1 and MARCHF8 potently restrict productive HSV-1 replication and assessed MARCHF8-mediated restriction of HSV-1 in detail. A functional RING-CH domain and a tyrosine-based motif, located in the N- and C-terminal cytoplasmic tail of MARCHF8, respectively, were required for HSV-1 restriction. For many RNA viruses, MARCHF8-mediated restriction has been associated with downregulation of viral envelope glycoproteins from the cell surface, thereby limiting their subsequent incorporation into nascent virions. However, while MARCHF8 expression did not affect virus entry, translocation of viral genome to the nucleus and immediate early (IE) gene expression, it did inhibit HSV-1 genomic replication, and therefore subsequent late gene expression and release of infectious virions. MARCHF8-mediated restriction of HSV-1 occurred independent of other cellular factors known to impact genomic replication of HSV-1, namely SAMHD1 and CD81, and could also proceed efficiently in cells expressing a functional cGAS-STING pathway. To our knowledge, these studies are the first to demonstrate MARCHF8-mediated restriction against a human DNA virus. Moreover, inhibition of HSV-1 genomic replication represents a novel mechanism of MARCHF8-mediated virus restriction that is distinct to its reported antiviral activity against different RNA viruses.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-60 of 60 references · Page 1 of 1

CITED BY

  • No citing papers are available for this paper.

Showing 0-0 of 0 citing papers · Page 1 of 1